Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Endocrine Journal|February 12, 2000
Hyperphosphatemia accelerates parathyroid cell proliferation and parathyroid hormone secretion in severe secondary parathyroid hyperplasiaY Hayakawa, Y Tanaka, H Funahashi, et al.
Journal of Medicinal Chemistry|July 21, 1998
Synthesis and pharmacological characterization of novel 6-fluorochroman derivatives as potential 5-HT1A receptor antagonistsT Yasunaga, T Kimura, R Naito, et al.
Bioorganic & Medicinal Chemistry|May 20, 2000
Discovery of a muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors among 2-[(1S,3S)-3-sulfonylaminocyclopentyl]phenylacetamide derivativesM Mitsuya, Y Ogino, K Kawakami, et al.
Journal of Medicinal Chemistry|October 13, 1995
Structure-activity relationships of cyclic pentapeptide endothelin A receptor antagonistsT Fukami, T Nagase, K Fujita, et al.
Chemical & Pharmaceutical Bulletin|November 14, 1997
2-(3-Pyridyl)thiazolidine-4-carboxamides. 1. Novel orally active antagonists of platelet-activating factor (PAF)H Nagaoka, H Hara, T Suzuki, et al.
Protein Engineering|September 1, 1996
The consequences of engineering an extra disulfide bond in the Penicillium camembertii mono- and diglyceride specific lipaseS Yamaguchi, K Takeuchi, T Mase, et al.
Biochemical and Biophysical Research Communications|December 3, 1999
The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailabilityA Kanatani, T Kanno, A Ishihara, et al.
Chemical & Pharmaceutical Bulletin|October 17, 1998
2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. II. Structure-activity relationships and active configuration of 2-(3-pyridyl)thiazolidine-4-carboxamides as platelet-activating factor receptor antagonistsT Suzuki, H Nagaoka, Y Kondo, et al.
Journal of Medicinal Chemistry|July 5, 1996
Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compoundsJ Ohmori, K Maeno, K Hidaka, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|August 28, 1998
[The effects of YM26818: 1-(2-dimethylaminoethyl)-1-(3,4,5-trimethoxyphenyl)urea and derivatives on pulmonary surfactant secretion and lung compliance]A Kimoto, M Saito, Y Hirano, et al.
Pageof 7